Team:Tokyo-NoKoGen/Safety

From 2011.igem.org

(Difference between revisions)
(Safety)
 
(3 intermediate revisions not shown)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
 
-
 
<html>
<html>
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
+
<head>
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
+
<meta http-equiv=Content-Type content="text/html; charset=ISO-8859-1">
-
This is a template page. READ THESE INSTRUCTIONS.
+
<title>SAFETY</title>
-
</div>
+
<meta name="viewport" content="width = 960, minimum-scale = 0.25, maximum-scale = 1.60">
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
+
<meta name="GENERATOR" content="Freeway 5 Express 5.6.0 Trial">
-
You are provided with this team page template with which to start the iGEM season. You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki. You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
+
<style type="text/css">
-
</div>
+
<!--
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
+
body { margin:0px; background-color:#fff; height:100% }
-
You <strong>MUST</strong> have a team description page, a project abstract, a complete project description, a lab notebook, and a safety page. PLEASE keep all of your pages within your teams namespace.
+
html { height:100% }
-
</div>
+
img { margin:0px; border-style:none }
-
</div>
+
button { margin:0px; border-style:none; padding:0px; background-color:transparent; vertical-align:top }
-
</html>
+
p:first-child { margin-top:0px }
 +
table { empty-cells:hide }
 +
.f-sp { font-size:1px; visibility:hidden }
 +
.f-lp { margin-bottom:0px }
 +
.f-fp { margin-top:0px }
 +
.f-x1 {  }
 +
.f-x2 {  }
 +
.f-x3 {  }
 +
em { font-style:italic }
 +
h1 { font-size:18px }
 +
h1:first-child { margin-top:0px }
 +
strong { font-weight:bold }
 +
.style27 { color:#000 }
 +
.style15 { font-family:Arial,Helvetica,sans-serif; font-size:20px }
 +
.style28 { color:#000 }
 +
.style16 { color:#000; font-family:Arial,Helvetica,sans-serif; font-weight:bold }
 +
.style17 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style18 { color:#000; font-family:Arial,Helvetica,sans-serif; margin-left:72px; text-indent:-72px }
 +
.style19 { color:#000; font-family:Arial,Helvetica,sans-serif; font-style:italic }
 +
.style20 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style21 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style22 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style23 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style9 { color:#00f94f; font-family:Chalkduster; font-size:70px; text-align:center }
 +
.style1 { text-align:center }
 +
.style6 { color:#000; font-family:Arial,Helvetica,sans-serif; font-size:14px }
 +
.style5 { color:#97238d }
 +
#fwNav1 { float:right;  padding:0; margin:0; list-style:none; }
 +
#fwNav1 .fwNavItem { width:auto;  float:left;margin:0; padding:0; border-right:1px Solid #0E0F10; border-top:0; border-bottom:0; border-left:1px Solid #647B86; position:relative; }
 +
#fwNav1 .fwNavItem a { display:block;color:#FFFFFF; text-decoration:none; background:url(Resources/transparent.gif) repeat; margin:0;padding:3px 10px 3px 10px; height:1%; }
 +
#fwNav1 .fwFirstChild { border-left:0; }
 +
#fwNav1 .fwLastChild { border-right:0; }
 +
#fwNav1 .fwNavItem a:hover, #fwNav1 .fwNavItem span a:hover, #fwNav1 .fwNavItem a:focus { color:#437286; text-decoration:none; background:url(Resources/transparent.gif) repeat; }
 +
#fwNav1 .fwNavItem a:active { text-decoration:none; background:url(Resources/transparent.gif) repeat; }
 +
#fwNav1 .fwNavItem a.fwCurrent, #fwNav1 .fwNavItem a.fwCurrent:hover { display:block; color:#839FAD; background:url(Resources/transparent.gif) repeat; }
 +
* html #fwNav1 { float:right; }
 +
* html #fwNav1 .fwNavItem a { float:left; height:1%; }
 +
-->
 +
</style>
 +
<!--[if lt IE 7]>
 +
<link rel=stylesheet type="text/css" href="css/ie6.css">
 +
<![endif]-->
 +
<script src="Resources/FW_Object.js" type="text/javascript"></script>
 +
</head>
 +
<body>
 +
<div id="PageDiv" style="position:relative; min-height:100%">
 +
<table border=0 cellspacing=0 cellpadding=0 width=896>
 +
<colgroup>
 +
<col width=37>
 +
<col width=858>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=10 colspan=2></td>
 +
<td height=10></td>
 +
</tr>
 +
<tr valign=top>
 +
<td height=24></td>
 +
<td height=24>
 +
<div style="width:858px; position:relative; z-index:1; overflow:visible">
 +
<div class="fwNavContainer1">
 +
<ul class="style1 f-fp f-lp" id="fwNav1">
 +
<li class="fwFirstChild fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">HOME</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Team"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">TEAM</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Project"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">PROJECT</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Parts"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">PARTS</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Notebook"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">NOTEBOOK</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Safety"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">SAFETY</span></strong></span></a></li>
 +
<li class="fwLastChild fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Sponsors"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">SPONSOR</span></strong></span></a></li>
 +
</ul>
 +
</div>
 +
</div>
 +
</td>
 +
<td height=24></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=37 height=1 alt="" style="float:left"></td>
 +
<td><img src="Resources/_clear.gif" border=0 width=858 height=1 alt="" style="float:left"></td>
 +
<td height=1><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
 +
<table border=0 cellspacing=0 cellpadding=0 width=961>
 +
<colgroup>
 +
<col width=960>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=126 bgcolor="#ffffff"><p class="style9 f-lp">Tokyo-NokoGen 2011</p>
 +
</td>
 +
<td height=126></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=960 height=1 alt="" style="float:left"></td>
 +
<td height=8><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
 +
<table border=0 cellspacing=0 cellpadding=0 width=938>
 +
<colgroup>
 +
<col width=11>
 +
<col width=926>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=933></td>
 +
<td height=933><p><span class="style27"><strong><span class="style15">&lt;Safety Proposal&gt;</span></strong></span></p>
 +
<p><span class="style16">-Would any of your project ideas raise safety issues in terms of:&nbsp;</span></p>
 +
<p class="style18"> &#9642; researcher safety,</p>
 +
<p class="style18"> &#9642; public safety, or</p>
 +
<p class="style18"> &#9642; environmental safety?</p>
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with E. coli</span><span class="style20"> laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle </span><span class="style19">E. coli</span><span class="style20"> and perform genetic engineering experiments.</span></p>
 +
<p><span class="style20">&nbsp; In our project, we are trying to construct the </span><span class="style19">E. coli</span><span class="style20"> that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an </span><span class="style19">E. coli</span><span class="style20"> machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,&nbsp;</span></p>
 +
<p class="style18"> &#9642; did you document these issues in the Registry?</p>
 +
<p class="style18"> &#9642; how did you manage to handle the safety issue?</p>
 +
<p class="style18"> &#9642; How could other teams learn from your experience?</p>
 +
<p><span class="style22">&nbsp;&nbsp; No,they don&#8217;t.&nbsp;Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network.&nbsp;We will use those genes that already have analyzed in peer-reviewed papers.&nbsp;Thus that new BioBrick part will not raise any safety issues.&nbsp;</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Is there a local biosafety group, committee, or review board at your institution?</span></p>
 +
<p class="style18"> &#9642; If yes, what does your local biosafety group think about your project?</p>
 +
<p class="style18"> &#9642; If no, which specific biosafety rules or guidelines do you have to consider in your country?</p>
 +
<p><span class="style22">&nbsp;&nbsp; Yes, there is. There is the committee of Tokyo University of Agriculture and Technology, and we are following its safety and ethical guidelines.</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></p>
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury.&nbsp;So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents.&nbsp;We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.</span></p>
-
<!-- *** End of the alert box *** -->
+
<p>&nbsp;</p>
 +
<p><span class="style16">-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></p>
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury. We should not only focus on avoiding serious accidents; if we minimize the number of no­injury accidents we will reduce the probability of more severe accidents.</span></p>
 +
                        <p class="f-lp"><span class="style22">&nbsp;&nbsp;We also suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. For example, has anyone identified a hazardous situation in the lab? What was the result and how was it handled? That should prevent the occurrence of more serious hazards.
 +
</span></p>
-
{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
 
-
|[[Image:Tokyo-NoKoGen_logo.png|200px|right|frame]]
 
-
|-
 
-
|
 
-
''Tell us more about your project.  Give us background.  Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
 
-
|[[Image:Tokyo-NoKoGen_team.png|right|frame|Your team picture]]
 
-
|-
 
-
|
 
-
|align="center"|[[Team:Tokyo-NoKoGen | Team Example]]
 
-
|}
 
-
<!--- The Mission, Experiments --->
 
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
</table>
-
!align="center"|[[Team:Tokyo-NoKoGen|Home]]
+
<table border=0 cellspacing=0 cellpadding=0 width=938>
-
!align="center"|[[Team:Tokyo-NoKoGen/Team|Team]]
+
<colgroup>
-
!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=Tokyo-NoKoGen Official Team Profile]
+
<col width=11>
-
!align="center"|[[Team:Tokyo-NoKoGen/Project|Project]]
+
<col width=926>
-
!align="center"|[[Team:Tokyo-NoKoGen/Parts|Parts Submitted to the Registry]]
+
<col width=1>
-
!align="center"|[[Team:Tokyo-NoKoGen/Modeling|Modeling]]
+
</colgroup>
-
!align="center"|[[Team:Tokyo-NoKoGen/Notebook|Notebook]]
+
<tr valign=top>
-
!align="center"|[[Team:Tokyo-NoKoGen/Safety|Safety]]
+
<td height=933></td>
-
!align="center"|[[Team:Tokyo-NoKoGen/Attributions|Attributions]]
+
<td height=933><p><span class="style27"><strong><span class="style15">&lt;SAFETY AND SECURITY QUESTIONS&gt;</span></strong></span></p>
-
|}
+
<p><span class="style16">-Would the materials used in your project and/or your final product pose:&nbsp;</span></p>
 +
<p class="style18"> &#9642; Risks to the safety and health of team members or others in the lab?</p>
 +
<p class="style18"> &#9642; Risks to the safety and health of the general public if released by design or accident?</p>
 +
<p class="style18"> &#9642; Risks to environmental quality if released by design or accident?</p>
 +
<p class="style18"> &#9642; Risks to security through malicious misuse by individuals, groups or states?</p>
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Our project is not expected to raise any safety issues, with respect to the safety of the researchers or the general public. We also do not expect any environmental issues or any risks of malicious use by individuals.</span><span class="style19">
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; We will only use typical laboratory E. coli strains (e.g., DH5α) and the engineering experiments we plan to carry out will not introduce any genes that are related to pathogenicity or virulence, or confer any selective advantage were they to be inadvertently or intentionally (maliciously) released into the environment.</span><span class="style19">
-
==Safety==
+
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor), and Prof. Ikebukuro (instructor), which have a biosafety level 2 facility to handle microorganisms and perform genetic engineering experiments. All the bacteria we handle, whether genetically modified or not, will be either stored at -80°C for future use or disposed of after autoclaving.</span><span class="style19">
-
Please use this page to answer the safety questions posed on the [[Safety | safety page]].
+
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Although our final product is meant to be used to clean the environment (capture cesium from radioactively contaminated water) it is not meant to be released into the environment. The final application would likely involve adding the cells to a large chamber containing contaminated water, and after some time releasing the water (void of cesium and bacteria). </span>
-
<div><span style="font-size:large">&lt;Safety Proposal&gt;</span></div>
+
-
<div>
+
-
<div><span style="line-height:19px;font-family:sans-serif;color:rgb(0,0,0)"><span style="font-size:large">
+
-
</span>
+
-
<table border="0" style="background-color:white;color:black;font-size:13px">
+
-
<td bgcolor="#ffff99" valign="top"><b><span style="font-size:medium">-Would any of your project ideas raise safety issues in terms of:&nbsp;</span></b><span style="font-size:medium"><br>
+
-
</span>
+
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">researcher safety,</span></li>
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">public safety, or</span></li>
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">environmental safety?</span></li></ul>
+
-
</ol>
+
-
<div>
+
-
<p><span><span style="font-size:medium">&nbsp;&nbsp;</span></span><span style="font-size:medium">Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> and perform genetic engineering experiments.</span></p>
+
-
</div>
+
-
<p><span><span style="font-size:medium">&nbsp; </span></span><span style="font-size:medium">In our project, we are trying to construct the </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.</span></p>
+
-
<div><span style="font-size:medium"><br>
+
-
</span></div>
+
-
<b><span style="font-size:medium">-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,&nbsp;</span></b><span style="font-size:medium"><br>
+
-
</span>
+
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">did you document these issues in the Registry?</span></li>
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">how did you manage to handle the safety issue?</span></li>
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">How could other teams learn from your experience?</span></li></ul>
+
-
</ol>
+
-
<div>
+
-
<p><span style="font-size:medium">&nbsp;&nbsp; No,they don’t.&nbsp;Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network.&nbsp;We will use those genes that already have analyzed in peer-reviewed papers.&nbsp;Thus that new BioBrick part will not raise any safety issues.&nbsp;</span></p>
+
-
</div>
+
-
<div><span style="font-size:medium"><br>
+
-
</span></div>
+
-
<b><span style="font-size:medium">-Is there a local biosafety group, committee, or review board at your institution?</span></b><span style="font-size:medium"><br>
+
-
</span>
+
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">If yes, what does your local biosafety group think about your project?</span></li>
+
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">If no, which specific biosafety rules or guidelines do you have to consider in your country?</span></li></ul>
+
-
</ol>
+
-
<div>
+
-
<p><span style="font-size:medium">&nbsp;&nbsp; Yes, there is. There is the committee of Tokyo University of
 
-
Agriculture and Technology, and we are following its safety and ethical guidelines.</span></p>
 
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Under what biosafety provisions will / do you operate?&nbsp;</span></p>
 +
 +
<p class="style18"> &#9642;Does your institution have its own biosafety rules and if so what are they?  Provide a link to them online if possible.</p>
 +
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp;Yes, our institution has own biosafety rules. This is managed by the Gene Research Center of the Tokyo University of Agriculture and Technology Research Center for Science and Technology [http://www.tuat.ac.jp/%7Eidenshi/index.html (only in Japanese)]. All students have to read the provided guidelines and apply for permission to do genetic engineering before we actually start experiments. All our members had read the guidelines and signed for agreement, and we all have been permitted to carry out genetic engineering experiments.</span><span class="style19">
 +
 +
 +
 +
<p class="style18"> &#9642; Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, have you discussed your project with them? Describe any concerns or changes that were made based on this review.</p>
 +
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp;We did not discuss our project directly with our Institutional Biosafety Committee, but we do follow their regulations and guidelines. Our instructors are monitoring our experiments closely, and they have not identified any safety issues. </span><span class="style19">
 +
 +
 +
<p class="style18"> &#9642; Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.</p>
 +
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; All team members have undergone a one year undergraduate lab course, which covered all relevant safety guidelines. Furthermore, team members are also currently carrying out their own research projects in laboratories in which part of their weekly lab meetings are dedicated to reviewing and discussing various safety issues. </span><span class="style19">
 +
 +
 +
 +
<p class="style18"> &#9642;Does your country have national biosafety regulations or guidelines?  If so, provide a link to them online if possible.</p>
 +
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp;  Japan’s Biosafety Regulations from the Ministery of the Environment:  </span><span class="style19">
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp;  English: www.bch.biodic.go.jp/english/law.html  </span><span class="style19">
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp;  Japanese: www.bch.biodic.go.jp/index.html.  </span><span class="style19">
 +
 +
 +
 +
 +
 +
</td>
 +
<td height=933></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=11 height=1 alt="" style="float:left"></td>
 +
<td><img src="Resources/_clear.gif" border=0 width=926 height=1 alt="" style="float:left"></td>
 +
<td height=1><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
</div>
</div>
-
<div><span style="font-size:medium"><br>
+
</body>
-
</span></div>
+
</html>
-
<b><span style="font-size:medium">-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></b><span style="font-size:medium"><br>
+
-
</span>
+
-
<p><span lang="EN-US"><span style="font-size:medium">&nbsp;&nbsp; Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury.&nbsp;</span></span><span style="font-size:medium">So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents.&nbsp;We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.</span></p>
+
-
</td>
+
-
</table>
+
-
</span></div>
+
-
</div>
+

Latest revision as of 10:35, 2 September 2011

SAFETY

Tokyo-NokoGen 2011

<Safety Proposal>

-Would any of your project ideas raise safety issues in terms of: 

▪ researcher safety,

▪ public safety, or

▪ environmental safety?

   Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with E. coli laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle E. coli and perform genetic engineering experiments.

  In our project, we are trying to construct the E. coli that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an E. coli machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.

 

-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, 

▪ did you document these issues in the Registry?

▪ how did you manage to handle the safety issue?

▪ How could other teams learn from your experience?

   No,they don’t. Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network. We will use those genes that already have analyzed in peer-reviewed papers. Thus that new BioBrick part will not raise any safety issues. 

 

-Is there a local biosafety group, committee, or review board at your institution?

▪ If yes, what does your local biosafety group think about your project?

▪ If no, which specific biosafety rules or guidelines do you have to consider in your country?

   Yes, there is. There is the committee of Tokyo University of Agriculture and Technology, and we are following its safety and ethical guidelines.

 

-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

   Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury. So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents. We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.

 

-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

   Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury. We should not only focus on avoiding serious accidents; if we minimize the number of no­injury accidents we will reduce the probability of more severe accidents.

  We also suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. For example, has anyone identified a hazardous situation in the lab? What was the result and how was it handled? That should prevent the occurrence of more serious hazards.

<SAFETY AND SECURITY QUESTIONS>

-Would the materials used in your project and/or your final product pose: 

▪ Risks to the safety and health of team members or others in the lab?

▪ Risks to the safety and health of the general public if released by design or accident?

▪ Risks to environmental quality if released by design or accident?

▪ Risks to security through malicious misuse by individuals, groups or states?

   Our project is not expected to raise any safety issues, with respect to the safety of the researchers or the general public. We also do not expect any environmental issues or any risks of malicious use by individuals.

   We will only use typical laboratory E. coli strains (e.g., DH5α) and the engineering experiments we plan to carry out will not introduce any genes that are related to pathogenicity or virulence, or confer any selective advantage were they to be inadvertently or intentionally (maliciously) released into the environment.

   Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor), and Prof. Ikebukuro (instructor), which have a biosafety level 2 facility to handle microorganisms and perform genetic engineering experiments. All the bacteria we handle, whether genetically modified or not, will be either stored at -80°C for future use or disposed of after autoclaving.

   Although our final product is meant to be used to clean the environment (capture cesium from radioactively contaminated water) it is not meant to be released into the environment. The final application would likely involve adding the cells to a large chamber containing contaminated water, and after some time releasing the water (void of cesium and bacteria).

 

-Under what biosafety provisions will / do you operate? 

▪Does your institution have its own biosafety rules and if so what are they? Provide a link to them online if possible.

  Yes, our institution has own biosafety rules. This is managed by the Gene Research Center of the Tokyo University of Agriculture and Technology Research Center for Science and Technology [http://www.tuat.ac.jp/%7Eidenshi/index.html (only in Japanese)]. All students have to read the provided guidelines and apply for permission to do genetic engineering before we actually start experiments. All our members had read the guidelines and signed for agreement, and we all have been permitted to carry out genetic engineering experiments.

▪ Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, have you discussed your project with them? Describe any concerns or changes that were made based on this review.

  We did not discuss our project directly with our Institutional Biosafety Committee, but we do follow their regulations and guidelines. Our instructors are monitoring our experiments closely, and they have not identified any safety issues.

▪ Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.

   All team members have undergone a one year undergraduate lab course, which covered all relevant safety guidelines. Furthermore, team members are also currently carrying out their own research projects in laboratories in which part of their weekly lab meetings are dedicated to reviewing and discussing various safety issues.

▪Does your country have national biosafety regulations or guidelines? If so, provide a link to them online if possible.

   Japan’s Biosafety Regulations from the Ministery of the Environment:

   English: www.bch.biodic.go.jp/english/law.html

   Japanese: www.bch.biodic.go.jp/index.html.